{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:16:06Z","timestamp":1775571366032,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00624-0","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T10:05:30Z","timestamp":1772445930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between interleukin-37 gene polymorphisms and susceptibility and clinical outcomes of rheumatoid arthritis: a meta-analysis and systematic review"],"prefix":"10.1186","volume":"10","author":[{"given":"Zihan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huapei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuehong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"3","key":"624_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.rdc.2017.04.003","volume":"43","author":"V Van Drongelen","year":"2017","unstructured":"Van Drongelen V, Holoshitz J. Human leukocyte antigen-disease associations in rheumatoid arthritis. Rheumatic Disease Clinics. 2017;43(3):363\u201376.","journal-title":"Rheumatic Disease Clinics"},{"key":"624_CR2","doi-asserted-by":"crossref","unstructured":"Chatzikyriakidou A, Voulgari PV, Lambropoulos A, Drosos AA. Genetics in rheumatoid arthritis beyond HLA genes: what meta-analyses have shown? In: Seminars in arthritis and rheumatism. Elsevier; 2013.","DOI":"10.1016\/j.semarthrit.2012.12.003"},{"key":"624_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2015.07.007","volume":"64","author":"TC Messemaker","year":"2015","unstructured":"Messemaker TC, Huizinga TW, Kurreeman F. Immunogenetics of rheumatoid arthritis: understanding functional implications. J Autoimmun. 2015;64:74\u201381.","journal-title":"J autoimmunity"},{"key":"624_CR4","doi-asserted-by":"crossref","unstructured":"Al-Tae FMD, Al-Harbi AA, Turki KW, Sood M. Interleukin -37 in rheumatoid arthritis: correlation with clinical severity and genetic polymorphisms in Mosul city, Iraq. Egypt J Immunol\/Egypt Assoc Immunologists. 30(2):162\u201373.","DOI":"10.55133\/eji.300215"},{"key":"624_CR5","unstructured":"Information NCfB. dbSNP: short genetic variations [online database]. 2025 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp. Bethesda, MD, USA: National Library of Medicine (US)."},{"key":"624_CR6","doi-asserted-by":"publisher","first-page":"696605","DOI":"10.3389\/fimmu.2021.696605","volume":"12","author":"Z Su","year":"2021","unstructured":"Su Z, Tao X. Current understanding of IL-37 in human health and disease. Front Immunol. 2021;12:696605.","journal-title":"Front Immunol"},{"issue":"11","key":"624_CR7","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.1944","volume":"11","author":"MF Nold","year":"2010","unstructured":"Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11(11):1014\u201322.","journal-title":"Nat Immunol"},{"key":"624_CR8","unstructured":"Ga SN-OW, Shea B, O\u2019Connell, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014."},{"issue":"1","key":"624_CR9","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s43166-025-00349-x","volume":"52","author":"M Abdo","year":"2025","unstructured":"Abdo M, Elmaghraby A, Abdelraouf FH, Elashmawy H, Ramadan H, Elsayed E, et al. Evaluation of IL-32 rs28372698 and IL-37 rs3811047 polymorphisms and their serum levels in rheumatoid arthritis patients. Egypt Rheumatol Rehabil. 2025;52(1):54.","journal-title":"Egypt Rheumatol Rehabil"},{"issue":"1","key":"624_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s43042-025-00793-6","volume":"26","author":"DF Bani-Wais","year":"2025","unstructured":"Bani-Wais DF, Ad\u2019hiah AH. Serum IL-37 levels are elevated in Iraqi women with rheumatoid arthritis and IL37 missense variants (rs3811046 and rs3811047) are associated with disease susceptibility. Egypt J Med Hum Genet. 2025;26(1):159.","journal-title":"Egypt J Med Hum Genet"},{"issue":"3","key":"624_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/iji.12007","volume":"40","author":"B Pei","year":"2013","unstructured":"Pei B, Xu S, Liu T, Pan F, Xu J, Ding C. Associations of the IL-1F7 gene polymorphisms with rheumatoid arthritis in C hinese H an population. Int J Immunogenet. 2013;40(3):199\u2013203.","journal-title":"Int J Immunogenet"},{"issue":"1","key":"624_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1995-7645(12)60204-1","volume":"6","author":"L-P Shi","year":"2013","unstructured":"Shi L-P, He Y, Liu Z-D. Correlation between single nucleotide polymorphism of rs3811047 in IL-1 F7 gene and rheumatoid arthritis susceptibility among Han population in central plains of China. Asian Pac J Trop Med. 2013;6(1):73\u201375.","journal-title":"Asian Pac J Trop Med"},{"key":"624_CR13","doi-asserted-by":"crossref","unstructured":"Zhang XY, Zuo Y, Li C, Tu X, Xu HJ, Guo JP, et al. IL1F7 gene polymorphism is not associated with rheumatoid arthritis susceptibility in the northern Chinese Han population: a case-Control study. Chin Med J. 131(2):171\u201379.","DOI":"10.4103\/0366-6999.222340"},{"key":"624_CR14","doi-asserted-by":"crossref","unstructured":"El-Sayed EH, Saleh MH, Al-Shahaly MH, Toraih EA, Fathy A. IL-37 gene variant (rs3811047): a marker of disease activity in rheumatoid arthritis: a pilot study. Autoimmunity. 51(8):378\u201385.","DOI":"10.1080\/08916934.2018.1551373"},{"issue":"4","key":"624_CR15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1213\/ANE.0000000000001596","volume":"123","author":"JE Dalton","year":"2016","unstructured":"Dalton JE, Bolen SD, Mascha EJ. Publication bias: the elephant in the review. Anesth Analg. 2016;123(4):812\u201313.","journal-title":"Anesth Analg"},{"issue":"4","key":"624_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.gene.6363766","volume":"2","author":"B Nd","year":"2001","unstructured":"Nd B, Di Giovine F, Silvestri T, Vannier E, Duff G, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes & Immun. 2001;2(4):222\u201328.","journal-title":"Genes & Immun"},{"key":"624_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/tan.13355","volume":"92","author":"J Wieli\u0144ska","year":"2018","unstructured":"Wieli\u0144ska J, Dratwa M, \u015awierkot J, Korman L, Iwaszko M, Wysocza\u0144ska B, et al. Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis. HLA. 2018;92:38\u201341.","journal-title":"HLA"},{"issue":"5","key":"624_CR18","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.5114\/aoms.2017.68945","volume":"13","author":"D Malinowski","year":"2017","unstructured":"Malinowski D, Paradowska-Gorycka A, Safranow K, Pawlik A. Interleukin 21 gene polymorphism rs2221903 is associated with disease activity in patients with rheumatoid arthritis. Archives Med Sci. 2017;13(5):1142\u201347.","journal-title":"Archives Med Sci"},{"issue":"8","key":"624_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/gtmb.2015.0064","volume":"19","author":"Erkol \u0130nal","year":"2015","unstructured":"Erkol \u0130nal, O G, \u00dc D, \u00d6 G, Yener M, \u015e \u00d6S, et al. The influence of polymorphisms of interleukin-17A and-17F genes on susceptibility and activity of rheumatoid arthritis. Genetic Test Mol Biomarker. 2015;19(8):461\u201364.","journal-title":"Genetic Test Mol Biomarker"},{"key":"624_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.imlet.2017.01.013","volume":"183","author":"OS Marwa","year":"2017","unstructured":"Marwa OS, Kalthoum T, Wajih K, Kamel H. Association of IL17A and IL17F genes with rheumatoid arthritis disease and the impact of genetic polymorphisms on response to treatment. Immunol Lett. 2017;183:24\u201336.","journal-title":"Immunol Lett"},{"issue":"2","key":"624_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-3083.2010.02411.x","volume":"72","author":"A Paradowska-Gorycka","year":"2010","unstructured":"Paradowska-Gorycka A, Wojtecka-Lukasik E, Trefler J, Wojciechowska B, Lacki J, Maslinski S. Association between IL-17F gene polymorphisms and susceptibility to and severity of rheumatoid arthritis (RA). Scand J Immunol. 2010;72(2):134\u201341.","journal-title":"Scand J Immunol"},{"issue":"2","key":"624_CR22","first-page":"212","volume":"29","author":"JT Cvetkovic","year":"2002","unstructured":"Cvetkovic JT, Wallberg-Jonsson S, Stegmayr B, Rantapaa-Dahlqvist S, Lefvert AK. Susceptibility for and clinical manifestations of rheumatoid arthritis are associated with polymorphisms of the TNF-alpha, IL-1beta, and IL-1Ra genes. The J Rheumatol. 2002;29(2):212\u201319.","journal-title":"The J Rheumatol"},{"issue":"3","key":"624_CR23","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1515\/jomb-2016-0008","volume":"35","author":"B Jenko","year":"2016","unstructured":"Jenko B, Praprotnik S, Tom\u0161ic M, Dol\u017ean V. NLRP3 and CARD8 polymorphisms influence higher disease activity in rheumatoid arthritis. J Med Biochem. 2016;35(3):319.","journal-title":"J Med Biochem"},{"key":"624_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2018.10.001","volume":"204","author":"V Hashemi","year":"2018","unstructured":"Hashemi V, Farrokhi AS, Tanomand A, Babaloo Z, Hojjat-Farsangi M, Anvari E, et al. Polymorphism of Foxp3 gene affects the frequency of regulatory T cells and disease activity in patients with rheumatoid arthritis in Iranian population. Immunol Lett. 2018;204:16\u201322.","journal-title":"Immunol Lett"},{"key":"624_CR25","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cytogfr.2019.10.003","volume":"49","author":"Z Huang","year":"2019","unstructured":"Huang Z, Xie L, Li H, Liu X, Bellanti JA, Zheng SG, et al. Insight into interleukin-37: the potential therapeutic target in allergic diseases. Cytokine Growth Factor Rev. 2019;49:32\u201341.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"624_CR26","doi-asserted-by":"publisher","first-page":"35802","DOI":"10.1038\/srep35802","volume":"6","author":"H Tan","year":"2016","unstructured":"Tan H, Deng B, Yu H, Yang Y, Ding L, Zhang Q, et al. Genetic analysis of innate immunity in Behcet\u2019s disease identifies an association with IL-37 and IL-18RAP. Sci Rep. 2016;6(1):35802.","journal-title":"Sci Rep"},{"issue":"12","key":"624_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/1744666X.2014.971014","volume":"10","author":"S Quirk","year":"2014","unstructured":"Quirk S, Agrawal DK. Immunobiology of IL-37: mechanism of action and clinical perspectives. Expert Rev Clin Immunol. 2014;10(12):1703\u201309.","journal-title":"Expert Rev Clin Immunol"},{"key":"624_CR28","doi-asserted-by":"publisher","first-page":"750753","DOI":"10.3389\/fimmu.2021.750753","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu F, Gao J, Kang J, Wang X, Niu Q, Liu J, et al. B cells in rheumatoid arthritis: pathogenic mechanisms and treatment prospects. Front Immunol. 2021;12:750753.","journal-title":"Front Immunol"},{"issue":"1","key":"624_CR29","first-page":"681678","volume":"2014","author":"S Bugatti","year":"2014","unstructured":"Bugatti S, Vitolo B, Caporali R, Montecucco C, Manzo A. B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers. Biomed Res Int. 2014;2014(1):681678.","journal-title":"Biomed Res Int"},{"key":"624_CR30","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"issue":"12","key":"624_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1177\/0961203316646462","volume":"25","author":"GC Wu","year":"2016","unstructured":"Wu GC, Li HM, Wang JB, Leng RX, Wang DG, Ye DQ. Elevated plasma interleukin-37 levels in systemic lupus erythematosus patients. Lupus. 2016;25(12):1377\u201380.","journal-title":"Lupus"},{"issue":"12","key":"624_CR32","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/apm.12467","volume":"123","author":"L Yang","year":"2015","unstructured":"Yang L, Zhang J, Tao J, Lu T. Elevated serum levels of I nterleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis. Apmis. 2015;123(12):1025\u201331.","journal-title":"Apmis"},{"issue":"1","key":"624_CR33","first-page":"19","volume":"23","author":"RM Fawzy","year":"2016","unstructured":"Fawzy RM, Ganeb SS, Said EA, Fouad NA. Serum level of interleukin-37 and expression of its mRNA in Ankylosing Spondylitis patients: possible role in osteoporosis. Egypt J Immunol. 2016;23(1):19\u201329.","journal-title":"The Egypt J Immunol"},{"issue":"1","key":"624_CR34","first-page":"795043","volume":"2015","author":"T Xia","year":"2015","unstructured":"Xia T, X-F Z, B-H Q, Fang H, J-J W, L-L Z, et al. Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1\/Th2\/Th17-related cytokines. Disease Markers. 2015;2015(1):795043.","journal-title":"Disease Markers"},{"key":"624_CR35","doi-asserted-by":"crossref","unstructured":"Zhu J, Xie C, Qiu H, Shi L. Correlation between level of interleukin-37 and rheumatoid arthritis progression. Int J Gener Med. 2021;1905\u201310.","DOI":"10.2147\/IJGM.S309436"},{"key":"624_CR36","doi-asserted-by":"crossref","unstructured":"Zhao P-W, Jiang W-G, Wang L, Jiang Z-Y, Shan Y-X, Jiang Y-F. Plasma levels of IL-37 and correlation with TNF-\u03b1, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One. 2014;9(5):e95346.","DOI":"10.1371\/journal.pone.0095346"},{"key":"624_CR37","doi-asserted-by":"crossref","unstructured":"Bulau A-M, Nold MF, Li S, Nold-Petry CA, Fink M, Mansell A, et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proceedings of the National Academy of Sciences. 2014): 2650\u201355, 111(7.","DOI":"10.1073\/pnas.1324140111"},{"issue":"6","key":"624_CR38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41419-018-0664-0","volume":"9","author":"M Zhao","year":"2018","unstructured":"Zhao M, Li Y, Guo C, Wang L, Chu H, Zhu F, et al. IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner. Cell Death Disease. 2018;9(6):582.","journal-title":"Cell Death Disease"},{"issue":"11","key":"624_CR39","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.4049\/jimmunol.1401810","volume":"194","author":"L Ye","year":"2015","unstructured":"Ye L, Jiang B, Deng J, Du J, Xiong W, Guan Y, et al. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J Immunol. 2015;194(11):5110\u201319.","journal-title":"The J Immunol"},{"issue":"1","key":"624_CR40","doi-asserted-by":"publisher","first-page":"38955","DOI":"10.1038\/srep38955","volume":"6","author":"D-W Wang","year":"2016","unstructured":"Wang D-W, Dong N, Wu Y, Zhu X-M, Wang C-T, Yao Y-M. Interleukin-37 enhances the suppressive activity of naturally occurring CD4+ CD25+ regulatory T cells. Sci Rep. 2016;6(1):38955.","journal-title":"Sci Rep"},{"issue":"23","key":"624_CR41","doi-asserted-by":"publisher","first-page":"12878","DOI":"10.3390\/ijms252312878","volume":"25","author":"S Lyu","year":"2024","unstructured":"Lyu S, Fang Z, Hu Y, Zhang M, He J, Wang X, et al. IL-37 isoform a prevents collagen-induced arthritis in mice by modulating the Th17\/Treg balance via IL1R8 receptors. Int J Mol Sci. 2024;25(23):12878.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"624_CR42","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1093\/rheumatology\/kew325","volume":"55","author":"G Cavalli","year":"2016","unstructured":"Cavalli G, Koenders M, Kalabokis V, Kim J, Tan AC, Garlanda C, et al. Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation. Rheumatology. 2016;55(12):2220\u201329.","journal-title":"Rheumatology"},{"issue":"1","key":"624_CR43","doi-asserted-by":"publisher","first-page":"42175","DOI":"10.1038\/srep42175","volume":"7","author":"D Yin","year":"2017","unstructured":"Yin D, Naji DH, Xia Y, Li S, Bai Y, Jiang G, et al. Genomic variant in IL-37 confers a significant risk of coronary artery disease. Sci Rep. 2017;7(1):42175.","journal-title":"Sci Rep"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00624-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00624-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00624-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:33:14Z","timestamp":1775568794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00624-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["624"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00624-0","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}